Healthcare

Suture Needle Market

By Segment, By Region, And Segment Forecasts, 2014 – 2023

Vertical: HealthcareBase Year: 201613 Sections

Executive Summary

Suture Needle Market — Snapshot

  • Market Size (2014)

    2014

    $2.89B

  • Projected (2023)

    2023

    $3.81B

  • CAGR (2014–2023)

    3.1%

    3.1%
  • Key Players

    101+

Suturing is a technique used to close cutaneous wounds. The prime goals of this technique includes closing dead spaces, reducing the risks of bleeding, strengthening wounds until healing, and making skin aesthetically pleasing. Various type of suture needles are available in the market such as, taper point needle, spatula needle, coronar tip needle, taper cutting, triangle needle, and others. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.

Notably, rising number of surgical procedures and favourable reimbursement scenario for a number of surgical procedures are promoting the growth of suture needles market globally. Road accidents have found to be responsible for rising surgical procedures and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research in 2017, it is found that low and middle-income countries bear the major burden of road traffic incidents worldwide.

Despite these drivers, there are some issues associated with suture needles market. Increasing incidence of needle stick injuries and easy availability of alternatives may hinder the growth of market.

Geographically, Americas region is commanding the largest market share owing to the improvement in reimbursement policies and rising healthcare expenditure. According to the American Medical Association, Medicare has made various significant amendments in Ambulatory Surgery Center payment system (ASC).

The global suture needles market is expected to reach USD 3,809.4 million by 2023 from USD 3,076.5 million in 2016. This market is expected to grow at a stable CAGR of 3.1% during the forecast period 2017-2023.

On the basis of shape, the global suture needles market is classified into straight, j shape, compound curve, half curved, and others. In 2016, straight needles segment commanded the largest market share of 25.4% and half curved needle is expected to grow at a fastest CAGR of 3.5% during the forecast period 2017 to 2023.

On the basis of type, the global suture needles market is classified into eyed and eyeless. Eyeless segment commanded the largest market share of 55.7% in 2016, and this segment is also expected to grow at a fastest CAGR of 3.4% during the forecast period 2017 to 2023.

Key Insight

The Suture Needle Market market is projected to grow at a CAGR of 3.1% from 2014 to 2023.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 5 regions: Asia Pacific, Europe, Middle East and Africa, South America, North America.
  • Market Segmentation: The market is analyzed across 5 segments: Straight, half curved, J Shape, Others, Compound curve. Forecasts are provided for each segment from 2014 to 2023.
  • Competitive Landscape: 101 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Suture Needle Market — Growth Trajectory

Research Objective

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of global suture needle market.

To provide comprehensive analysis of suture needle industry and its sub-segments in the global market, thereby providing a detailed structure of the industry. To provide detailed insights into the factors driving and restraining the growth of global suture needle market.To estimate the market size of global suture needle from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.To analyze global suture needle market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.To compare the products with respect to the various players in the marketTo provide country wise market value analysis for various segments of suture needle marketTo understand the demand-supply scenario and provide gap analysis of the industryTo analyze and provide upcoming technologies and trends in suture needle marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.

Suture Needle Market — Growth Trajectory

Straight
half curved

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Shape Shape is broken down into: Straight, J Shape, Compound curve, half curved, Others.
  • Type Type is broken down into: Eyed, Eyeless.
  • End Users End Users is broken down into: Ambulatory Surgical Centers, Hospital, Clinics, End Users_Others.

Geographic Analysis

Regional market breakdown

  • Asia Pacific Asia Pacific market size reached $599.10M in 2014 and is projected to reach $810.10M by 2023, growing at a CAGR of 3.4%.
  • Europe Europe market size reached $833.50M in 2014 and is projected to reach $1.11B by 2023, growing at a CAGR of 3.2%.
  • Middle East and Africa Middle East and Africa market size reached $497.80M in 2014 and is projected to reach $600.70M by 2023, growing at a CAGR of 2.1%.
  • South America South America market size reached $200.50M in 2014 and is projected to reach $231.20M by 2023, growing at a CAGR of 1.6%.
  • North America North America market size reached $763.30M in 2014 and is projected to reach $1.06B by 2023, growing at a CAGR of 3.7%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Suture Needle Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2016

  • Historical Period

    2014 – 2016

  • Forecast Period

    2016 – 2023

  • Primary Interviews

    150+

Research Process

Historical data (2014–2016) and forecast period (2016–2023)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Suture Needle Market — Competitive Analysis

Bargaining Power of Suppliers

The suppliers in the global suture needles industry are the developers and manufacturers of suture needles. Currently, a number of suppliers are present in the market due to the availability of huge opportunities for the development, huge demand, and increasing government support. Currently, the market consists of large number of players manufacturing suture needles, however, few existing key companies capture significant share in the global market and have the capability of fluctuating the costs of the devices. Switching cost of these suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the other device manufacturing companies. The overall bargaining power of suppliers in the global suture needles market is medium.

Bargaining Power of Buyers

The bargaining power of the buyers is medium to high in the global suture needles market due to the presence of huge number of device providers in the industry. Because of the difference in the services and products provided by the manufacturer, the buying power of the buyer increasing with increasing number of choices of the products. Thus, the number of manufacturers increases the selection arena of the sellers for the buyers, which leads to the high bargaining power. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing, which affects the power of a buyer in the industry.

Threat of New Entrants

The threat of new entrants is medium in the global suture needles market due to developing the potential market. Any manufacturing company is trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. Moreover, the technological advancements in the industry are more likely to attract new companies to enter the business. The rise in the demand for the curved suture needle into the market owing to its potential growth in the coming future is expected to attract the currently established and other manufacturers to focus more on this segment. There is a strong hold of the big companies in the global market, which can make the entry of the new players a bit difficult.

Threat of Substitutes

The threat of substitutes in the global suture needles market is pretty high. Buyer’s propensity to substitute is high due to great availability of substitutes in this market. However, quality and trust issue for the products provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.

Intensity of Rivalry

The degree of competition in the global suture needles market is considered to be high. Differentiation among existing players and introduction of the newer products is increasing the intensity of rivalry in the market. Suture needles manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in partnering with the established organizations and welcoming tie-ups. Moreover, the players are also developing advanced products for differentiating their brand from competitors.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Suture Needle Market.

Regional Market Size (USD Mn)

Market estimates by geography (2023)

USD Mn

InsightEurope leads with $1.11B by 2023, while North America is projected to grow fastest at a 3.7% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201420162023CAGRSHARE
Asia Pacific$599.10M$708.40M$810.10M3.4%21%
Europe$833.50M$975.90M$1.11B3.2%29%
Middle East and Africa$497.80M$553.20M$600.70M2.1%16%
South America$200.50M$217.80M$231.20M1.6%6%
North America$763.30M$916.20M$1.06B3.7%28%
Total$2.89B$3.37B$3.81B3.1%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2023)

Straight
half curved
J Shape
Others
Compound curve
02725448161088

Segment Market Share

  • Straight26%
  • half curved24%
  • J Shape17%
  • Others17%
  • Compound curve16%

Total Market Size

$3.81B

Market by Segment (2023)

APPLICATIONREVENUE ($B)GROWTH RATEMARKET PENETRATION
Straight$988.20M3.1%
89%
half curved$918.90M3.1%
89%
J Shape$666.40M3.1%
72%
Others$636.00M3.1%
53%
Compound curve$599.90M3.1%
89%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Suture Needle Market — Key Findings

Analytical insights on Suture Needle Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Suture Needle Market market is projected to reach $3.81B by 2023, growing at 3.1% CAGR. The Straight segment holds the largest share.

Market Dynamics

Suture needles plays an important role in the placement of sutures in tissues. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.

The suture needles market is expecting a stable growth during the forecasted period 2017-2023. The major driving factors for the market are increasing number of surgical procedures, and improvement in reimbursement policies. However, easy availability of alternatives, and rising number of needle stick injuries may hamper the market growth in coming future.

Market Drivers

Facts & InformationWith the rising limiest of chronic diseases, need of surgical procedures has also been escalatingAs per the 2015 statistics suggested by Eurostat, cataract sugary, and colonoscopy were the two most common surgical procedures performed in European region. It is observed that in the year 2015, cataract sugary way performed one thousand times per 100,000 inhabitants specifically in Germany, Sweden, the Czech Republic, Luxembourg, Finland, Malta, Estonia, Austria, Portugal and France. Other common procedures include bronchoscopies, and transluminal coronary angioplastiesAccording to the Australian Institute of Health and Welfare, during 2015-16, there were 10.6 million hospitalization, and 1 in 4 hospitalization involved a surgical procedureAmerican Society of Plastic Surgeons stated that in the year 2016, around 1,780,987 cosmetic surgical procedures were performedRoad accidents hare also found to be responsible for rising surgical procedures, and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research it 2017, it is fond that low and middle income countries bear the major burden of road traffic incidents worldwideA study published in the International Journal of Contemporary Pediatrics, in 2016, stated that during 2014 to 2016, 195 children were admitted for road traffic accident in India and around 6.7% went through surgical procedure for complex injury

Interpretation

Suturing is an indispensable process during injury, incision or surgery as it helps in wound healing. For different wounds or surgical procedures distinct stitching styles have been used such as vertical mattress, layered closure, horizontal mattress, running suture, and many others. Demand for surgical procedures is on rise across the globe as surgery has become standard treatment for various health conditions

Impact

Suture needles market is expected to showcase tremendous growth on account of the rising number of surgical procedures as in most common surgeries suturing is an important aid for wound closure

Growth Enhancement Factor

This is an important aid in various surgical procedures such as endoscope assisted sugary, cosmetic plastic sugary, bariatric surgery, and others. The increasing number of surgical procedures is expected to escalated the demand for suture needles

Conclusion

The primary goals of suturing are reducing the risks of bleeding, closing dead space, strengthening wounds until healing, and to attain aesthetically pleasing and functional results. For all the facts and information, it is observed that rise in number of surgical procedures will also boost the suture needles market

Market Opportunities

Fact & Information

Suturing is the most common method used for the ulcer wound managementAccording to a 2016 study published in Wound Repair and Regeneration, it is found that occurrence of venous leg ulcers (VLU) is three to four times higher in population older than 80 years. Incidence of pressure ulcers (PU) five to seven times higher in people older than was as compared to 65 to 70 years old populationIt is also reported that care for chronic wound costs around USD 10 billion annually, and would care in persons aged 65 and older accounts for the majority of these costsAccording the report of WHO published in 2015, the geriatric population is excepted to double and reach 2.1 billion by 2050

Interpretation

Older adults are more vulnerable towards chronic wounds than younger people, and also wound healing slows with age. So, the rising geriatric population offers great opportunities to marketers to come up with the advancement in suture needles

Market Restraints

Fact & Information

There is continuous surge for the adoption of technologically advanced suturing productsIn past few years various alternatives of suture needles have come forward such as staples, tapes, tissue adhesives, and othersBioWeld1 system by lonMed is a cold plasma system designed for surgical incision closureEthicon has also introduced various suturing products such as Dermabond Advanced Topical Skin Adhesive, and others

Interpretation

In past fay years various technologically advanced suturing products have been introduced in the market. These newly introduced products have tendency shift the market trend in their favor in near future

Impact

The alternatives introduced by existing, and new market players can strongly impact the growth of the market as these alternative products are continuously gaining popularity due to their better cosmetic results

Conclusion

From all the fats, and information, it is concluded that due to the benefits offered by the available alternatives such as less pain, better cosmetic outcome, and less time consumption, over conventional suturing may hamper the suture needle market

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2023)

Value (USD Mn)
Straight
half curved
J Shape
Others
Compound curve

Companies

Key companies profiled in Suture Needle Market

Profiles of 101 companies operating in the Suture Needle Market market, including revenue, employee count, and market positioning where available.

Showing 101 of 101 companies

Roboz Surg

Roboz Surgical Instrument

Healthcare

Company Headquarter: Gaithersburg, Maryland, United States Workforce: 11-50 employees Company Working: Roboz Surgical Instrument company is engaged in the wholesale distribution of surgical and other instruments, apparatus, and equipments.

RevenueN/A
Employees50
Market CapN/A
FoundedN/A
United States, North America
Novavax, I

Novavax, Inc.

Healthcare

Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa

Revenue$0.5B
Employees2,500
Market CapN/A
Founded1986
Maryland, US
Ology Bios

Ology Bioservices, Inc

Healthcare

Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).

RevenueN/A
Employees800
Market CapN/A
Founded1998
Florida, US
Cleveland

Cleveland Biolabs, Inc

Healthcare

Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.

Revenue$0.0B
Employees150
Market CapN/A
Founded2002
New York, US
Fabentech

Fabentech Biotech

Healthcare

Company Headquarters: Lyon, US Founded: 2009 Workforce: ~25 Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms

RevenueN/A
Employees25
Market CapN/A
Founded2008
Lyon, US
Elusys The

Elusys Therapeutics, Inc

Healthcare

Company Headquarters: New Jersey, US Founded: 1998 Workforce: ~25 Company Working: Elusys Therapeutics, Inc. is a commercial-stage biopharmaceutical company that develops antibody-based products to treat infectious diseases. It has partnerships with renowned biodefense associations, including the Centers for Disease Control and Prevention (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), and the National Institute of Allergy and Infectious Diseases (US). It supplies its anthrax antitoxin products from the Strategic National Stockpile (US). Moreover, it is a wholly owned subsidiary of NightHawk Biosciences (US) and is expanding NightHawk's biodefense space while also complementing NightHawk’s RapidVax platform, which is designed to specifically target emerging biological threats

RevenueN/A
Employees25
Market CapN/A
Founded1997
New Jersey, US
Page 1 of 17
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Suture Needle Market

Starting from
$4,950